Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn’s Disease
Romain Clément(Montreal Heart Institute), Christine Des Rosiers(Montreal Heart Institute), Judy H. Cho(Cedars-Sinai Medical Center), Steven R. Brant(Rutgers, The State University of New Jersey), Richard H. Duerr(University of Pittsburgh), Alain Bitton(McGill University Health Centre), Anik Forest(Montreal Heart Institute), Dermot McGovern(Salford Royal NHS Foundation Trust), Bertrand Bouchard(Montreal Heart Institute), L. Philip Schumm(Chicago Department of Public Health), Ramnik J. Xavier(Massachusetts General Hospital), Sylvie Lesage(Hôpital Maisonneuve-Rosemont), John D. Rioux(Institute for Molecular Medicine Finland), Ashwin N. Ananthakrishnan(Harvard University), Mark S. Silverberg(Sinai Health System), Gabrielle Boucher(Montreal Heart Institute), Mark Lazarev(Johns Hopkins University)
Cited by 29
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k